H.R. 448105th CongressHouse Bill

Prostate Cancer Diagnosis and Treatment Act of 1997

Introduced in the HouseDead

This bill died when its Congress ended.

Bills don't carry over between Congresses. Without re-introduction in a new session, it cannot advance.

Prostate Cancer Diagnosis and Treatment Act of 1997 - Amends title XVIII (Medicare) of the Social Security Act to provide for coverage of services for the early detection of prostate cancer and certain drug treatments for such cancer. Requires the Secretary of Health and Human Services to establish fee schedules for such services. Amends Federal law to cover such detection and treatment services for veterans as a preventive health service. Amends the Public Health Service Act to authorize appropriations for certain public health programs related to prostate cancer research and education. Directs the Administrator of the Agency for Health Care Policy and Research to: (1) conduct and support research on prostate cancer health services and procedures; and (2) provide for the development, periodic review, and updating of clinically relevant guidelines, standards of quality, performance measures, and medical review criteria.

Introduced Jan 9, 1997
1
Introduced

Filed in the House

2
Passed House
3
Passed Senate
4
Became Law

This house bill has been filed and is working its way through Congress. It will need to pass both the House and the Senate, then be signed by the President to become law.

Who introduced this

SB

Spencer Bachus

Republican

U.S. Representative · AL-6

Introduced solo — no cosponsors joined.

Ask AI About This Bill

Get plain-language answers with direct quotes from the bill text.

to ask questions about this bill.

Your Representatives

Enter your address to see how your representatives voted on this bill.

Your address is only used to find your district and is never saved. See how it works

Votes

Public Opinion

No votes yet — be the first to weigh in.

to cast your vote

Your voice matters — let representatives know where you stand.

Comments

No comments yet. to be the first to weigh in.